Profound Medical Valuation
| PRN Stock | CAD 7.57 0.09 1.17% |
At this time, the company appears to be overvalued. Profound Medical Corp holds a recent Real Value of C$6.34 per share. The prevailing price of the company is C$7.57. Our model determines the value of Profound Medical Corp from analyzing the company fundamentals such as Operating Margin of (4.26) %, shares outstanding of 30.05 M, and Return On Equity of -0.66 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Profound Medical's valuation include:
Price Book 3.2612 | Enterprise Value | Enterprise Value Ebitda (7.93) | Price Sales 19.1791 | Enterprise Value Revenue 10.4609 |
Overvalued
Today
Please note that Profound Medical's price fluctuation is moderately volatile at this time. Calculation of the real value of Profound Medical Corp is based on 3 months time horizon. Increasing Profound Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Profound Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profound Stock. However, Profound Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.57 | Real 6.34 | Hype 7.57 | Naive 8.2 |
The intrinsic value of Profound Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Profound Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Profound Medical Corp helps investors to forecast how Profound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profound Medical more accurately as focusing exclusively on Profound Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Profound Medical's intrinsic value based on its ongoing forecasts of Profound Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Profound Medical's closest peers.
Profound Medical Cash |
|
Profound Valuation Trend
Knowing Profound Medical's actual value is paramount for traders when making sound investment determinations. Using both Profound Medical's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Profound Medical Total Value Analysis
Profound Medical Corp is at this time estimated to have takeover price of 170.43 M with market capitalization of 227.5 M, debt of 1.74 M, and cash on hands of 27.05 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Profound Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
170.43 M | 227.5 M | 1.74 M | 27.05 M |
Profound Medical Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Profound Medical was at this time reported as 1.69. The company recorded a loss per share of 1.66. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Profound Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Profound Medical has an asset utilization ratio of 15.21 percent. This suggests that the Company is making C$0.15 for each dollar of assets. An increasing asset utilization means that Profound Medical Corp is more efficient with each dollar of assets it utilizes for everyday operations.Profound Medical Ownership Allocation
Profound Medical owns a total of 30.05 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Profound Medical Profitability Analysis
The company reported the revenue of 10.68 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 8.02 M.About Profound Medical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Profound Medical Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Profound Medical Corp based exclusively on its fundamental and basic technical indicators. By analyzing Profound Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Profound Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Profound Medical. We calculate exposure to Profound Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Profound Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7 M | 7.4 M | |
| Pretax Profit Margin | (2.60) | (2.73) | |
| Operating Profit Margin | (3.10) | (3.25) | |
| Net Loss | (2.60) | (2.73) | |
| Gross Profit Margin | 0.66 | 0.39 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.